Fact CheckerSign in

NCT07152990Not yet recruiting

Prevalence of Nocturnal Hypoventilation in Obese Subjects Fiited With Continuous Positive Airway Pressure for Obstructive Sleep Apnea / Hypopnea Syndrome

Prevalence of Nocturnal Hypoventilation Diagnosed by Transcutaneous Oxy-capnography in a Population of Obese Subjects Fitted With Continuous Positive Airway Pressure for Obstructive Sleep Apnea Hypopnea Syndrome.

Source: ClinicalTrials.gov · Last updated 3 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

CAPNOSOH study is a single-center study conducted at Toulouse University Hospital, aiming to estimate the prevalence of obese and apneic subjects maintaining nocturnal hypoventilation under continuous positive airway pressure (CPAP).

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
139 (estimated)
First submitted
25 Aug 2025
Start date
Sept 2025
Primary completion date
May 2027
Lead sponsor
University Hospital, Toulouse
Diseases
Obesity
NCT number
NCT07152990

What you commit to

  • Study type: Interventional
  • Planned participants: 139
  • From Sept 2025 to the primary completion date, May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient under legal protection measure
  • Non-compliant patients
  • Pregnant or breast-feeding women (assessed on questioning)

Who the study is looking for

  • Obese patients (Body Mass Index \> 30 kg/m2)
  • Fitted by one of the following providers: ASTEN, Vitalaire, Orkyn, ISIS, RespiO2, BASTIDE for \> 3 months with compliance of more than 4 consecutive hours per night in average during 3 months
  • "Good quality" criteria for continuous positive airway pressure (CPAP) treatment: compliance \> 4 consecutive hours per night, unintentional leaks \< limit defined by the manufacturer, residual AHI \< 10/h
  • Aged 18 to 80
  • Affiliated or beneficiaries of the social security system or equivalent
  • Having given written informed consent
  • Able to understand instructions and information given

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Toulouse - Hopital Larrey
Coordinator of this site? Confirm its status
ToulouseFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.